Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis

NCT ID: NCT02123628

Last Updated: 2014-04-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE4

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-06-30

Study Completion Date

2012-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to compare the efficacy and tolerance of 6- versus 12-week antibiotic therapy in patients with diabetic foot osteomyelitis treated medically.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of this randomized multicenter clinical study is to compare the efficacy and tolerance of 6 versus 12-week antibiotic treatment in patients with diabetic foot osteomyelitis treated medically as no equivalent data are currenty available in the literature.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

antibiotic therapy

patients are treated with a 6 week-duration of antibiotic therapy :

* Rifampin IP and PO twice daily, 10mg/kg /12H
* Levofloxacin IV and PO 500-750mg once daily
* Doxycycline PO 200mg once daily
* Trimethoprim- sulfamethoxazole IV and PO 800/160mg thrice daily
* Fusidic acid PO 500mg twice daily
* Linezolid IV and PO 600mg twice daily
* Ciprofloxacin IV and PO 750to 1000mg/12h
* Cefotaxime IV 100mg/kg in three IV infusions daily
* Ceftriaxone IV,intramuscularly or subcutaneously 2g once daily
* Cefepime IV ou intra-muscularly 2g /8-12h

Group Type ACTIVE_COMPARATOR

duration of the antibiotic therapy

Intervention Type DRUG

12 week-duration of antibiotic therapy

patients are treated with a 12 week-duration of antibiotic therapy :

* Rifampin IP and PO twice daily, 10mg/kg /12H
* Levofloxacin IV and PO 500-750mg once daily
* Doxycycline PO 200mg once daily
* Trimethoprim- sulfamethoxazole IV and PO 800/160mg thrice daily
* Fusidic acid PO 500mg twice daily
* Linezolid IV and PO 600mg twice daily
* Ciprofloxacin IV and PO 750to 1000mg/12h
* Cefotaxime IV 100mg/kg in three IV infusions daily
* Ceftriaxone IV,intramuscularly or subcutaneously 2g once daily
* Cefepime IV ou intra-muscularly 2g /8-12h

Group Type ACTIVE_COMPARATOR

duration of the antibiotic therapy

Intervention Type DRUG

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

duration of the antibiotic therapy

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

- Rifampin - Levofloxacin - Doxycycline - Trimethoprim- sulfamethoxazole - Fusidic acid - Linezolid - Ciprofloxacin - Cefotaxime - Ceftriaxone - Cefepime

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* diabetic patients treated non-surgically (i.e. without amputation or resection of the infected bone) for an osteomyelitis of the foot complicating a neuropathic foot without ischemia of the foot defined as the absence of any pedal pulse. Patients aged of 18 years or more were included if they had type 2 diabetes and osteomyelitis of the foot (i.e.below the ankle).

Exclusion Criteria

* Patients with gangrene or who require bone resection or amputation when osteomyelitis of the foot was diagnosed
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Tourcoing Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Eric M Senneville, MD, PhD

Role: STUDY_DIRECTOR

Dron Hospital of Tourcoing France

Alina Tone, MD

Role: PRINCIPAL_INVESTIGATOR

Dron Hospital Tourcoing France

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dron Hospital

Tourcoing, Nord, France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

References

Explore related publications, articles, or registry entries linked to this study.

Tone A, Nguyen S, Devemy F, Topolinski H, Valette M, Cazaubiel M, Fayard A, Beltrand E, Lemaire C, Senneville E. Six-week versus twelve-week antibiotic therapy for nonsurgically treated diabetic foot osteomyelitis: a multicenter open-label controlled randomized study. Diabetes Care. 2015 Feb;38(2):302-7. doi: 10.2337/dc14-1514. Epub 2014 Nov 20.

Reference Type DERIVED
PMID: 25414157 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2006-00625-14

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.